139 related articles for article (PubMed ID: 22122801)
1. Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression.
Ben-Hamo R; Efroni S
Genome Med; 2011 Nov; 3(11):77. PubMed ID: 22122801
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-gene association as a prognostic biomarker in cancer exposes disease mechanisms.
Ben-Hamo R; Efroni S
PLoS Comput Biol; 2013; 9(11):e1003351. PubMed ID: 24278004
[TBL] [Abstract][Full Text] [Related]
3. hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elements.
Ben-Hamo R; Zilberberg A; Cohen H; Efroni S
Oncotarget; 2016 Apr; 7(17):23170-81. PubMed ID: 27036038
[TBL] [Abstract][Full Text] [Related]
4. Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme.
Li WB; Chen HY; Zhang W; Yan W; Shi R; Li SW; Jiang T
Chin Med J (Engl); 2013; 126(15):2881-5. PubMed ID: 23924460
[TBL] [Abstract][Full Text] [Related]
5. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
Toraih EA; Aly NM; Abdallah HY; Al-Qahtani SA; Shaalan AA; Hussein MH; Fawzy MS
Tumour Biol; 2017 Nov; 39(11):1010428317726842. PubMed ID: 29110584
[TBL] [Abstract][Full Text] [Related]
7. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.
Qiu S; Lin S; Hu D; Feng Y; Tan Y; Peng Y
J Transl Med; 2013 Jan; 11():10. PubMed ID: 23302469
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients.
Géczi D; Nagy B; Szilágyi M; Penyige A; Klekner Á; Jenei A; Virga J; Birkó Z
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064637
[TBL] [Abstract][Full Text] [Related]
9. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
10. Correction: Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression.
Ben-Hamo R; Efroni S
Genome Med; 2012; 4(11):87. PubMed ID: 23194430
[No Abstract] [Full Text] [Related]
11. Analysis of microarray data for identification of key microRNA signatures in glioblastoma multiforme.
Shaji SK; Sunilkumar D; Mahalakshmi NV; Kumar GB; Nair BG
Oncol Lett; 2019 Aug; 18(2):1938-1948. PubMed ID: 31423264
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of miRNA expression profile between primary and recurrent glioblastoma.
Bo LJ; Wei B; Li ZH; Wang ZF; Gao Z; Miao Z
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3579-86. PubMed ID: 26502847
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in
Liu HW; Lee PM; Bamodu OA; Su YK; Fong IH; Yeh CT; Chien MH; Kan IH; Lin CM
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31783691
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy.
Schnabel E; Knoll M; Schwager C; Warta R; Mock A; Campos B; König L; Jungk C; Wick W; Unterberg A; Debus J; Herold-Mende C; Abdollahi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803955
[TBL] [Abstract][Full Text] [Related]
15. Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma.
Bai S; Wu Y; Yan Y; Shao S; Zhang J; Liu J; Hui B; Liu R; Ma H; Zhang X; Ren J
Sci Rep; 2020 Aug; 10(1):13659. PubMed ID: 32788609
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA hsa_circ_0005114-miR-142-3p/miR-590-5p-adenomatous polyposis coli protein axis as a potential target for treatment of glioma.
Wei B; Wang L; Zhao J
Oncol Lett; 2021 Jan; 21(1):58. PubMed ID: 33281969
[TBL] [Abstract][Full Text] [Related]
17. Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma.
Sun J; Gong X; Purow B; Zhao Z
PLoS Comput Biol; 2012; 8(7):e1002488. PubMed ID: 22829753
[TBL] [Abstract][Full Text] [Related]
18. Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies.
Ben-Hamo R; Efroni S
BMC Syst Biol; 2012 Jan; 6():3. PubMed ID: 22236809
[TBL] [Abstract][Full Text] [Related]
19. High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.
Cunha PP; Costa PM; Morais CM; Lopes IR; Cardoso AM; Cardoso AL; Mano M; Jurado AS; Pedroso de Lima MC
Hum Mol Genet; 2017 Nov; 26(22):4375-4387. PubMed ID: 28973155
[TBL] [Abstract][Full Text] [Related]
20. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
